Centre for Innovative Biomedicine and Biotechnology

CIBB is a Research Unit of excellence at the University of Coimbra, and an international reference in the domains of Biomedicine and Biotechnology.

Data from 2018-2023



Researchers from

Faculties of Medicine, Pharmacy, Sciences and Economics

Coimbra Clinical Unit (ULS Coimbra)

Key collaborators from biotech and pharma industry

More than 700 members

309 Integrated PhD-holders

232 PhD students

171 Other collaborators

Research-oriented Advanced Training
Student hat illustration

Participation in 8 PhD Programs

Certificate illustration

Participation in 7 MSc Programs

White board illustration

European Training Networks (H2020 MSCA‑ETN)

Highly Internationalized Research

50% of publications as

International Collaborations

Funding illustration

International Projects funded by the European Union, International Foundations and the Private Sector

Clinicians at CIBB
Flag illustration

>50 clinicians

In several areas

Technology Transfer
Certificate illustration

31 active IP families
10 Granted IP

Start-up illustration

10 active Spin-offs

Contract illustration

> 20 academia-industry contracts

Awards illustration

Pfizer Award in basic research

Badge illustration

L'Oréal Portugal Medal of Honor for Women in Science

Award illustration

Euretina Award

Several CIBB Researchers have leadership roles in major scientific societies in Portugal (e.g. Neuroscience, Biochemistry, Stem Cells & Cell Therapies and Pharmacology) and elsewhere (e.g. Human Genetics, Microbiology, Clinical Investigation and Controlled Release Society).

Science Communication
Newspaper illustration

> 4500 news | AdvertisingValue >16 M € | Audiences >200 M

Computer screen illustration

> 26 K social networks followers

Group of people illustration

Public Engagement Activities | > 32 K people reached | > 400 researchers involved | > 25 non-academic collaborations

Data from 2018 - 2023

We use cookies to improve your visit to our website.